Abstract

Neuroaxonal damage is the pathological substrate of permanent disability in various neurological disorders. Reliable quantification and longitudinal follow-up of such damage are important for assessing disease activity, monitoring treatment responses, facilitating treatment development and determining prognosis. The neurofilament proteins have promise in this context because their levels rise upon neuroaxonal damage not only in the cerebrospinal fluid (CSF) but also in blood, and they indicate neuroaxonal injury independent of causal pathways. First-generation (immunoblot) and second-generation (enzyme-linked immunosorbent assay) neurofilament assays had limited sensitivity. Third-generation (electrochemiluminescence) and particularly fourth-generation (single-molecule array) assays enable the reliable measurement of neurofilaments throughout the range of concentrations found in blood samples. This technological advancement has paved the way to investigate neurofilaments in a range of neurological disorders. Here, we review what is known about the structure and function of neurofilaments, discuss analytical aspects and knowledge of age-dependent normal ranges of neurofilaments and provide a comprehensive overview of studies on neurofilament light chain as a marker of axonal injury in different neurological disorders, including multiple sclerosis, neurodegenerative dementia, stroke, traumatic brain injury, amyotrophic lateral sclerosis and Parkinson disease. We also consider work needed to explore the value of this axonal damage marker in managing neurological diseases in daily practice.

Keywords

NeurofilamentMedicineAmyotrophic lateral sclerosisMultiple sclerosisContext (archaeology)Traumatic brain injuryNeurosciencePathologyDiseaseBiomarkerImmunologyBiologyBiochemistryImmunohistochemistry

MeSH Terms

AgingAmyotrophic Lateral SclerosisBiomarkersBipolar DisorderBrain InjuriesTraumaticDementiaHumansHuntington DiseaseImmunoassayMultiple SclerosisNeurofilament ProteinsParkinson DiseaseStroke

Affiliated Institutions

Related Publications

Publication Info

Year
2018
Type
review
Volume
14
Issue
10
Pages
577-589
Citations
1787
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1787
OpenAlex
54
Influential

Cite This

Michael Khalil, Charlotte E. Teunissen, Markus Otto et al. (2018). Neurofilaments as biomarkers in neurological disorders. Nature Reviews Neurology , 14 (10) , 577-589. https://doi.org/10.1038/s41582-018-0058-z

Identifiers

DOI
10.1038/s41582-018-0058-z
PMID
30171200

Data Quality

Data completeness: 81%